Jose A Apud, M.D.
National Institute of Mental Health (NIMH)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jose A Apud, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:14 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT00548327 · The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) GenotypeNational Institute of Mental Health (NIMH) · terminated · Schizophrenia, Memory Disorders, Cognition Disorders · principal investigator
- Ph1NCT00057707 · Effects of Modafinil on Brain Function in Patients With SchizophreniaNational Institute of Mental Health (NIMH) · completed · Schizophrenia, Schizoaffective Disorder · principal investigator
- Ph2NCT00044083 · Clinical Trial of Tolcapone for Cognition in SchizophreniaNational Institute of Mental Health (NIMH) · terminated · Schizophrenia · principal investigator
- N/ANCT00001260 · Brain Tissue Collection for Neuropathological StudiesNational Institute of Mental Health (NIMH) · terminated · Bipolar Disorder, Depression, Anxiety Disorders · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.